Bremelanotide: A Breakthrough in Treating Hypoactive Sexual Desire Disorder
Introduction to Bremelanotide Bremelanotide, known chemically as PT-141, is a synthetic analog of melanocyte-stimulating hormone (MSH) designed primarily to address sexual dysfunction, particularly in women suffering from hypoactive sexual desire disorder (HSDD). This peptide is administered through subcutaneous injection and works as a central nervous system agent. It acts by activating melanocortin receptors in theRead More